Cargando…
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
OBJECTIVE: Significant efforts are currently being made to identify novel biomarkers for the diagnosis and risk stratification of prostate cancer (PCa). Metabolomics can be a very useful approach in biomarker discovery because metabolites are an important read-out of the disease when characterized i...
Autores principales: | Drago, Denise, Andolfo, Annapaola, Mosca, Ettore, Orro, Alessandro, Nocera, Luigi, Cucchiara, Vito, Bellone, Matteo, Montorsi, Francesco, Briganti, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185872/ https://www.ncbi.nlm.nih.gov/pubmed/34037347 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0617 |
Ejemplares similares
-
Novel Metabolic Signatures of Prostate Cancer Revealed by (1)H-NMR Metabolomics of Urine
por: Yang, Bo, et al.
Publicado: (2021) -
Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022) -
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
por: Huang, Hsiang-Po, et al.
Publicado: (2023) -
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness
por: Damascelli, Anna, et al.
Publicado: (2021) -
An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)